Balabhadrapatruni V S K Chakravarthi
Overview
Explore the profile of Balabhadrapatruni V S K Chakravarthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
4703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Roy M, Chakravarthi B, Jayabaskaran C, Karande A, Chakravarty A
Dalton Trans
. 2019 Oct;
48(42):16126.
PMID: 31603176
Correction for 'Impact of metal binding on the antitumor activity and cellular imaging of a metal chelator cationic imidazopyridine derivative' by Mithun Roy et al., Dalton Trans., 2011, 40, 4855-4864.
12.
Eich M, Chandrashekar D, Rodriguez Pen A M, Robinson A, Siddiqui J, Daignault-Newton S, et al.
Prostate
. 2019 Aug;
79(14):1629-1639.
PMID: 31376196
Background: Recent microarray and sequencing studies of prostate cancer showed multiple molecular alterations during cancer progression. It is critical to evaluate these molecular changes to identify new biomarkers and targets....
13.
Chakravarthi B, Pena M, Agarwal S, Chandrashekar D, Balasubramanya S, Jabboure F, et al.
Neoplasia
. 2018 Aug;
20(9):894-904.
PMID: 30121007
Genomic and transcriptome sequencing of bladder cancer (BLCA) has identified multiple molecular alterations during cancer progression. Many of these identified genetic and epigenetic changes play a role in the progression...
14.
Chakravarthi B, Chandrashekar D, Balasubramanya S, Robinson A, Carskadon S, Rao U, et al.
Prostate
. 2018 Jul;
78(16):1311-1320.
PMID: 30051493
Prostate cancer (PCa) is one of the most frequently diagnosed cancers among men. Many molecular changes have been detailed during PCa progression. The gene encoding the transcription factor ERG shows...
15.
Chakravarthi B, Goswami M, Pathi S, Dodson M, Chandrashekar D, Agarwal S, et al.
Prostate
. 2018 May;
78(9):693-694.
PMID: 29744932
No abstract available.
16.
Chakravarthi B, Chandrashekar D, Agarwal S, Balasubramanya S, Pathi S, Goswami M, et al.
Mol Cancer Res
. 2017 Oct;
16(7):1125-1137.
PMID: 29025958
In aggressive prostate cancers, the oncoprotein STMN1 (also known as stathmin 1 and oncoprotein 18) is often overexpressed. STMN1 is involved in various cellular processes, including cell proliferation, motility, and...
17.
Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B, et al.
Neoplasia
. 2017 Jul;
19(8):649-658.
PMID: 28732212
Genomics data from The Cancer Genome Atlas (TCGA) project has led to the comprehensive molecular characterization of multiple cancer types. The large sample numbers in TCGA offer an excellent opportunity...
18.
Wang X, Qiao Y, Asangani I, Ateeq B, Poliakov A, Cieslik M, et al.
Cancer Cell
. 2017 Jun;
31(6):844-847.
PMID: 28609659
No abstract available.
19.
Wang X, Qiao Y, Asangani I, Ateeq B, Poliakov A, Cieslik M, et al.
Cancer Cell
. 2017 Mar;
31(4):532-548.e7.
PMID: 28344039
Transcription factors play a key role in the development of diverse cancers, and therapeutically targeting them has remained a challenge. In prostate cancer, the gene encoding the transcription factor ERG...
20.
Chakravarthi B, Goswami M, Pathi S, Dodson M, Chandrashekar D, Agarwal S, et al.
Prostate
. 2016 Aug;
77(1):10-21.
PMID: 27550065
Background: Our goal was to investigate de novo purine biosynthetic gene PAICS expression and evaluate its role in prostate cancer progression. Methods: Next-generation sequencing, qRTPCR and immunoblot analysis revealed an...